Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Product & Service Segment | Product & Service, Products, , Instruments, Organ-on-a-Chip Devices, Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others, , Services |
| Application Segment | Drug Discovery, Toxicology Research, Others |
| End-User Segment | Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Others |
|---|---|
| Regions & Countries |
|
Increasing demand for personalized medicine propels the organ-on-a-chip market. Growing government and private institution funding fuels the growth of the organ-on-chip market.
Lack of standardization and low throughput of current organ-on-chip technology restrain the growth of organ on the chip market.
The development of multi-organ-on-chip systems represents a significant opportunity to grow the organ-on-a-chip market.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The competitive landscape of the industry is defined by established pharmaceutical and biotechnology companies that provide pharmaceutical treatment products and advanced technology products which are competing for market share. To expand their range of products, major companies are taking part in strategic efforts such as collaborations, investment, collaboration, and new launches. Companies are proactively using multiple strategies to tackle the increasing need for organ chips.
For instance, in December 2022, Tessara Therapeutics entered into collaboration with France-based organ-on-a-chip company NETRI on the development of a next-generation brain-on-a-chip model for neurological disease research.
Source:(https://biomelbourne.org/tessara-therapeutics-and-netri-to-collaborate-on-the-development-of-next-generation-3d-brain-on-a-chip-model/)
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Emulate | ••• | ••• | ••• | ••• |
| Inc. | ••• | ••• | ••• | ••• |
| MIMETAS B.V. | ••• | ••• | ••• | ••• |
| Valo Health | ••• | ••• | ••• | ••• |
| Nortis | ••• | ••• | ••• | ••• |
| Inc. | ••• | ••• | ••• | ••• |
| AxoSim | ••• | ••• | ••• | ••• |
| BICO - THE BIO CONVERGENCE COMPANY | ••• | ••• | ••• | ••• |
| CN Bio Innovations Ltd | ••• | ••• | ••• | ••• |
| SynVivo | ••• | ••• | ••• | ••• |
| Inc. | ••• | ••• | ••• | ••• |
| The Charles Stark Draper Laboratory | ••• | ••• | ••• | ••• |
| Inc | ••• | ••• | ••• | ••• |
| AlveoliX AG | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the Global Organ-On-a-Chip market was USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.
North America held the major market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX % from 2024 to 2031.
The Europe region is the fastest growing market with a CAGR of XX% from 2024 to 2031 and it is projected that it will grow at a CAGR of XX% in the future.
Asia Pacific accounted for a market share of over XX% of the global revenue with a market size of USD XX million.
Latin America had a market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The organ-on-a-chip held the highest market revenue share in 2024.
Organ-on-chips are devices that include small-scale, organic, or artificial tissues created inside microfluidic chips. The chips are designed to maintain tissue-specific functions and control cell microenvironments to more closely mimic human physiology. The growing interest in organ-on-a-chip (OoC) technology may be ascribed to the convergence of advancements in tissue engineering and microfabrication. OoCs are becoming increasingly popular as the next generation of investigative tools for studying human pathophysiology and the effects of treatments on the body. Since there are as many OoCs as solicitations, it is difficult for modern academics to understand what makes one OoC more useful for a certain application than another.
The growth of the market is attributed to the rising need for kidneys, liver, heart, and lungs. By designing operational organs in labs that can address the shortage of donor organs, this technique can help meet the need for organ transplants. Still, the market's progress may be hampered by the soaring costs of organ-on-a-chip devices and the early stage of organ-on-chip technology development. Despite this, increasing healthcare costs in developing nations and a rise in harmful diseases, the need for organ transplantation, and animal testing for medication development are all expected to contribute to market expansion.
With the help of the above study about the organ-on-a-chip market, it can be concluded that the market for organ-on-a-chip worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.
With the help of the above study about the organ-on-a-chip market, it can be concluded that the market for organ-on-a-chip worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.
★ Reviews
Rate this report
| Product & Service | Product & Service, Products, , Instruments, Organ-on-a-Chip Devices, Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others, , Services |
| Application | Drug Discovery, Toxicology Research, Others |
| End-User | Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Others |
| List of Competitors | Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc, AlveoliX AG |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Organ on a chip Systems Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
In June 2023, PMI and TissUse GmbH signed a cooperation agreement to use the Multi-Organ-Chip (MOC) platform from TissUse and PMI's InHALES technology.
Source:(https://www.marketsandmarketsblog.com/progressive-projections-organs-on-chips-market-on-a-steady-climb.html)
In June 2023, MatTek Life Sciences announced a strategic partnership with AIM Biotech enabling the availability of AIM Biotech portfolio for sale through MatTek.
Source:(https://www.mattek.com/mattek-aim-partner-on-organ-on-a-chip-systems/#:~:text=EpiDerm%E2%84%A2-,MatTek%20and%20AIM%20Biotech%20Partner%20on%20Advanced%203D%20Tissue,%2Don%2Da%2DChip%20Systems&text=Boston%2C%20MA%20%E2%80%93%20June%201%2C,available%20for%20sale%20through%20MatTek.)
In June 2023, Dynamic42 raised an undisclosed amount through a Series A funding round to expand internationally.
Source:(https://silverwoodpartners.com/healthcare-private-placement-and-ma-transactions-review-week-ending-june-19-2023/#:~:text=Dynamic42%3A%20The%20company%20raised%20an,data%20related%20to%20human%20physiology.)
In June 2023, Emulate launched Emulate Chip-A1 to widen its applications in cancer and cosmetic markets.
Source:(https://www.businesswire.com/news/home/20230626795938/en/Emulate-Unveils-Chip-A1-Expanding-Organ-on-a-Chip-Technology-Applications-Within-the-Cancer-and-Cosmetics-Markets)
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Organ on a chip Systems Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global organ on a chip systems market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.